title: Successful treatment of multicentric Castleman's disease with intracranial and retroperitoneal tumors.
authors.affiliation: The First Department of Internal Medicine, Saitama Medical School, Iruma-gun.
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: T
authors.initials: T
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Sakata
authors.forename: N
authors.initials: N
authors.lastname: Kawai
authors.forename: A
authors.initials: A
authors.lastname: Matsuda
authors.forename: H
authors.initials: H
authors.lastname: Kayano
authors.forename: K
authors.initials: K
authors.lastname: Hirashima
authors.forename: M
authors.initials: M
authors.lastname: Matsutani
authors.forename: M
authors.initials: M
authors.lastname: Bessho
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D005871:Castleman Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D015850:Interleukin-6 / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant; D012008:Recurrence; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D015850:Interleukin-6